Literature DB >> 11232771

Detection of peptostreptococcus micros DNA in clinical samples by PCR.

M P Riggio1, A Lennon1, A Smith1.   

Abstract

Peptostreptococcus micros is a gram-positive anaerobic coccus which, although considered to be a natural commensal of the human oral cavity, is associated with periodontal, endodontal and peritonsillar infections. Identification of the organism has to date relied upon conventional culture methods and biochemical analyses. The purpose of this study was to develop a PCR method for rapid and specific identification of this organism in clinical samples. A pair of primers was selected, each of which was specific at the 3' end for P. micros DNA; they were used in the PCR assay, resulting in a 1074-bp product. The primers were shown to be specific for P. micros DNA as no PCR products were obtained when genomic DNA extracts from a wide range of other Peptostreptococcus species and other oral bacteria were used as templates. The PCR assay was then applied to the identification of P. micros DNA in subgingival plaque samples from adult periodontitis patients and pus samples from subjects with acute dento-alveolar abscesses. Confirmation of specific amplification of P. micros DNA was obtained by digestion of PCR products with the restriction endonuclease RsaI, which gives a unique restriction profile for P. micros, and DNA sequencing. Sixty-eight subgingival plaque samples from 18 patients were analysed, of which 19 (28%) were positive for P. micros DNA; the proportion of patients carrying P. micros DNA in at least one sampled site was 11 (61%) of 18. Twenty (71%) of 28 pus samples analysed by PCR contained P. micros DNA. These results confirm that P. micros may be involved in the aetiology of acute dentoalveolar abscesses and adult periodontitis. The PCR assay provides a more rapid and reliable alternative to conventional methods for identification of P. micros in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232771     DOI: 10.1099/0022-1317-50-3-249

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Identification of oral peptostreptococcus isolates by PCR-restriction fragment length polymorphism analysis of 16S rRNA genes.

Authors:  Marcello P Riggio; Alan Lennon
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 2.  Microbiology and treatment of acute apical abscesses.

Authors:  José F Siqueira; Isabela N Rôças
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Characterization of the salivary microbiome in people with obesity.

Authors:  Yujia Wu; Xiaopei Chi; Qian Zhang; Feng Chen; Xuliang Deng
Journal:  PeerJ       Date:  2018-03-16       Impact factor: 2.984

4.  Parvimonas micra Spondylodiscitis: A Case Report and Systematic Review of the Literature.

Authors:  D C van Duijvenbode; J W P Kuiper; R M Holewijn; A Stadhouder
Journal:  J Orthop Case Rep       Date:  2018 Sep-Oct

5.  Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection.

Authors:  Smruti Pushalkar; Bidisha Paul; Qianhao Li; Jian Yang; Rebeca Vasconcelos; Shreya Makwana; Juan Muñoz González; Shivm Shah; Chengzhi Xie; Malvin N Janal; Erica Queiroz; Maria Bederoff; Joshua Leinwand; Julia Solarewicz; Fangxi Xu; Eman Aboseria; Yuqi Guo; Deanna Aguallo; Claudia Gomez; Angela Kamer; Donna Shelley; Yindalon Aphinyanaphongs; Cheryl Barber; Terry Gordon; Patricia Corby; Xin Li; Deepak Saxena
Journal:  iScience       Date:  2020-02-26

6.  16S rRNA region based PCR protocol for identification and subtyping of Parvimonas micra.

Authors:  C Ota-Tsuzuki; A T P Brunheira; M P A Mayer
Journal:  Braz J Microbiol       Date:  2008-12-01       Impact factor: 2.476

7.  Salivary microbiome differences in prepubertal children with and without adrenal androgen excess.

Authors:  Brittany K Wise-Oringer; Anne Claire Burghard; Heekuk Park; Richard J Auchus; Sharon E Oberfield; Anne-Catrin Uhlemann
Journal:  Pediatr Res       Date:  2021-08-02       Impact factor: 3.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.